# Stage 5 planning readiness FrontierLab separates **planning readiness** from **planning authorization**. A run can have current evidence, human review, hypotheses and a researcher-selected method while the Planning Agent remains completely disabled. ## Recorded M2 state The current recorded biomedical path has: - two source-bound researcher-reviewed claims; - two citation-linked hypotheses from the bounded Muse Glimmer continuation; - a canonical Method Evaluation with M2 selected; - no generated plan; - no Stage 5 planning authorization. Selected method: **M2 — Structure-based dual-pH histidine-scanning computational design** Canonical IDs: - context ID: `ee7f790ba48474bb63a935f6108f1e698121a404d93a5bf0389946ba2932dcf8` - evaluation ID: `00c440f3a78a95a1703725ea261b992ab51551d1dedd9cf41ba481dd0954f231` ## What the readiness packet proves `frontierlab.planning_readiness.build_planning_readiness(run)` first re-runs `require_evaluation(run)`. If that exact evaluation is stale, altered or no longer bound to the current reviewed evidence/hypotheses, readiness fails. A valid packet records: ```text status = READY_FOR_EXPLICIT_PLANNING_APPROVAL planning_approved = false model_call_authorized = false planning_model_called = false plan_generated = false ``` This is an eligibility/precondition record, not an approval record. ## Open reproducibility checks M2 currently has three unresolved reproducibility checks: - **data** — complete design inputs, intermediate ranking outputs and raw validation data are not yet packaged; - **code** — the original ADAPT implementation or a reproducible executable alternative has not been independently verified; - **environment** — dependency versions, computational environment and protonation/modeling settings have not been reconstructed. The recorded parameters, protocol and metrics are source-documented but have not been reproduced by FrontierLab. ## Planning obligations Any later Stage 5 draft must retain these constraints: 1. **Design-input provenance** — record structural/design inputs and candidate-ranking provenance. 2. **Executable design stack** — identify ADAPT or a named reproducible alternative. 3. **Computational environment** — record dependencies and protonation/modeling settings. 4. **Matched-pH controls** — prespecify acidic vs physiological-pH comparisons and falsification conditions. 5. **Fab-level validation** — keep Fab readouts distinct from cell/full-antibody measurements. 6. **Orthogonal SPR** — where feasible, use SPR on monomeric Fab to separate intrinsic affinity from avidity/stoichiometry. 7. **Avidity/stoichiometry caveat** — do not overinterpret apparent cell-binding affinity mechanistically. 8. **Structure/search bias** — surface structural-model uncertainty and the histidine-centered search assumption; M1 remains a comparator for histidine-independent solutions. 9. **Replication/falsification** — include independent replication, stopping criteria and explicit falsification conditions. ## Evidence boundary The packet distinguishes: - **selected-method evidence**: `PMC6927761`; - **all currently reviewed evidence available to planning**: `PMC4314675`, `PMC6927761`. The Planning Agent, if later authorized, may use only reviewed evidence and must cite the selected method's source. ## Recorded builder `python -m scripts.planning_readiness_recorded` reconstructs the exact October 28 extraction, human review, reviewed continuation and Method Evaluation, then emits a readiness packet with **zero model calls**. The recorded researcher-selection provenance remains separate from the canonical Method Evaluation so the latter continues to rebuild exactly from code. ## UI When a current evaluation exists and no plan has been generated, Streamlit exposes: **Planning readiness · pre-approval contract** The panel shows the selected method, open reproducibility checks and all required obligations. It does not add a new authorization control. The existing Stage 5 checkbox remains the only researcher authorization for draft planning. ## Scientific boundary Planning readiness does not establish that M2 works, that the original experiment is reproducible, or that any proposed plan is safe/effective. It only establishes that FrontierLab's current source-bound workflow state is internally eligible to ask the researcher for an explicit Stage 5 decision.